The US FDA has approved donanemab, a treatment for Alzheimer’s disease that helps the body remove the hallmark plaque that builds up in the brain and causes dementia. The US FDA has approved donanemab, a treatment for Alzheimer’s disease that helps the body remove the hallmark plaque that builds up in the brain and causes dementia.
America gets another Alzheimer’s drug in its arsenal: FDA approves Eli Lilly’s treatment which slows symptoms down
